CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic
RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA – May 07, 2020: CluePoints, the premier provider of Risk-Based…
Read More
Beyond COVID-19: The New Normal in Risk-Based Monitoring (RBM) and Quality Management (RBQM)
Join our next webinar to learn first-hand how the CluePoints and Parexel partnership is driving best-in-class Risk-Based Quality Management Strategies to support clinical development. This…
Read More
EPS Corporation Signs Groundbreaking Agreement To Drive Increased Quality And Safety Using CluePoints RBQM Solution
King of Prussia, PA – April 14, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials,…
Read More
Early Risk Detection During the COVID-19 Crisis – Your Questions Answered
On Tuesday, March 31, 2020, CluePoints delivered a webinar centred around the critical importance of early risk detection. Our presenter also shared insights on how…
Read More
CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA – April 06, 2020: CluePoints, the premier provider of Risk-Based…
Read More
Webinar Recording: The Critical Importance of Early Risk Detection with a Special Feature Addressing COVID-19
We're delighted to announce that the recording for our COVID-19 webinar has been posted! The clinical research industry is in the midst of adopting Risk-Based…
Read More
Complimentary COVID-19 Risk Assessment Package Available To All at No Cost
As advised in the coronavirus guidances recently issued by FDA, EMA, and MHRA, it is important to perform a fresh risk assessment for each study…
Read More
CluePoints’ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
MITIGATING THE IMPACT ON SITE MONITORING EFFORTS DUE TO COVID-19 King of Prussia, PA – March 18, 2020: CluePoints, the premier provider of Risk-Based Trial…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
2,500
Platform Users
350
Studies De-Risked
15,000
Issues Detected